Ribosomal Protein L22-Like1 (RPL22L1) Mediates Sorafenib Sensitivity via ERK in Hepatocellular Carcinoma

Scientists identified a novel candidate oncogene, RPL22L1, which was markedly elevated in HCC and contributed to HCC malignancy and adverse patient survival.